Cost effectiveness of a general practice chronic disease management plan for coronary heart disease in Australia

Derek P Chew1, Robert Carter, Bree Rankin

  • 1Flinders Medical Centre, Flinders University, Flinders Drive, Bedford Park, SA 5042, Australia. derek.chew@flinders.edu.au

Insights

A new Australian program for coronary heart disease (CHD) management in general practice is likely cost-effective. This approach optimizes current therapies, offering substantial benefits to the community.

Area of Science:

  • Cardiovascular Medicine
  • Health Economics
  • Preventive Cardiology

Background:

  • The cost-effectiveness of general practice-based coronary heart disease (CHD) management programs in Australia is not well-established.
  • Existing management strategies for CHD patients require economic evaluation within the Australian healthcare context.

Purpose of the Study:

  • To evaluate the economic viability of a secondary prevention program for CHD patients managed in Australian general practice.
  • To determine the incremental cost-effectiveness ratio (ICER) of an optimized CHD management program.

Main Methods:

  • An economic model was developed to assess a secondary prevention program.
  • The program involved clinical assessment, pharmacotherapy optimization, lifestyle modification, a disease registry, and financial incentives.
  • Cost-effectiveness was measured using the ICER in Australian dollars per disability-adjusted life year (DALY) prevented.

Main Results:

  • In 2006, CHD accounted for 263,487 DALYs in Australia.
  • The proposed program estimated an annual cost of $115,650,000.
  • With a 15% reduction in mortality/disability and 40% uptake, the ICER was $8081 per DALY prevented; sensitivity analysis yielded up to $38,316 per DALY.

Conclusions:

  • Current CHD therapies offer proven benefits for reducing morbidity and mortality.
  • A general practice-based program effectively applying these therapies is likely cost-effective.
  • Such a program promises significant and sustainable advantages for the Australian community.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...